Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 nn » 5 non (Expand Search), 59 nn (Expand Search), 5 nm (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 nn » 5 non (Expand Search), 59 nn (Expand Search), 5 nm (Expand Search)
-
7801
-
7802
Gsdf inhibits <i>cyp19a1a</i> transcription via competitive interaction with Ncoa5.
Published 2022“…<b>(F)</b> Effect of <i>ncoa5</i> (<i>ncoa5-A</i> and <i>ncoa5-B</i>) RNAi on the Gsdf-A/Gsdf-B-induced repression of <i>cyp19a1a</i>. qPCR analysis of <i>ncoa5</i> and <i>cyp19a1a</i> in the EPC cells after transfection with different plasmids and <i>ncoa5-A/B</i> siRNA for 24 h (*<i>P</i><0.05). …”
-
7803
Schematic representation of possible mechanism of action of OKN-007 in IC3752 pGBM tumor bearing mice.
Published 2015“…By removing 6-O-sulfates on HS chains and mobilizing protein ligands from HSPG sequestration in the extracellular environment (3), the SULF-2 can increase the solubility of a variety of growth factors (e.g. PDGF) (4) thus increasing the activation of PDGFR-α and downstream signaling pathways in tumor cells (5) [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0134276#pone.0134276.ref098" target="_blank">98</a>]. …”
-
7804
(A) The proportion of fast MyHC myotubes is decreased in Igf-2 deficient mice (maternal disomy Chromosome 7 - MatDi) at E14
Published 2011“…(B) Embryo immunoblotting for Igf-2 demonstrates a stage related increase in Igf-2 protein between E10.5 and E15.5 in WT and absence of Igf-2 in MatDi embryos at E14.5 and E15.5 Tracks 1–4 E10.5, E13.5, E14.5 and E15.5 WT embryos respectively, Track 5 E14.5 MatDi, Track 6 E15.5 MatDi and Track 7 E15.5 WT. …”
-
7805
-
7806
-
7807
-
7808
-
7809
-
7810
-
7811
-
7812
image1_Astragaloside IV Inhibits Galactose-Deficient IgA1 Secretion via miR-98-5p in Pediatric IgA Nephropathy.tif
Published 2021“…Experiments with the dual-luciferase reporter confirmed that miR-98-5p might target C1GALT1. The overexpression of miR-98-5p in DAKIKI cells decreased both the mRNA and protein levels of C1GALT1 and increased the levels of Gd-IgA1 levels; these effects were reversed by co-transfection with the C1GALT1 plasmid, and vice versa. …”
-
7813
datasheet1_Astragaloside IV Inhibits Galactose-Deficient IgA1 Secretion via miR-98-5p in Pediatric IgA Nephropathy.zip
Published 2021“…Experiments with the dual-luciferase reporter confirmed that miR-98-5p might target C1GALT1. The overexpression of miR-98-5p in DAKIKI cells decreased both the mRNA and protein levels of C1GALT1 and increased the levels of Gd-IgA1 levels; these effects were reversed by co-transfection with the C1GALT1 plasmid, and vice versa. …”
-
7814
-
7815
-
7816
-
7817
-
7818
-
7819
-
7820